País: Malta
Idioma: anglès
Font: Medicines Authority
MEROPENEM
Sandoz Pharmaceuticals d.d. Verovškova Ulica 57, SI-1000 Ljubljana, Slovenia
J01DH02
MEROPENEM 1 g
POWDER FOR SOLUTION FOR INFUSION OR INJECTION
MEROPENEM 1 g
POM
ANTIBACTERIALS FOR SYSTEMIC USE
Withdrawn
2010-09-09
PROPOSED MOCK UP A healthy decision Sandoz Ltd, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom. T: 01276 698020 F: 01276 698324 W: www.uk.sandoz.com E: sandoz.artwork@me.com ARTWORK PROOF BOX Ref: Proof no. RA Approved? Colours: Dimensions: Date prepared: Date approved: Prepared by: Approved by: Fonts: 001.1 16/07/2010 DW 16/07/2010 VM Yes Licence application - add Malta details Black Black 20% 340 x 540 mm Helvetica Font size: 10pt Artwork/RA Checklist: Product name Strength/dosage PL number Storage Pack size Warnings Excipients Braille Meropenem belongs to a group of medicines called carbapenem antibiotics. It works by killing bacteria, which can cause serious infections. • Infection affecting the lungs (pneumonia) • Lung and bronchial infections in patients suffering from cystic fibrosis • Complicated urinary tract infections • Complicated infections in the abdomen • Infections that you can catch during or after the delivery • Complicated skin and soft tissues infections • Acute bacterial infection of the brain (meningitis) Meropenem may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection. DO NOT USE MEROPENEM • if you are allergic (hypersensitive) to meropenem or any of the other ingredients of Meropenem (listed in section 6. Futher information). • if you are allergic (hypersensitive) to other antibiotics such as penicillins, cephalosporins, or carbapenems as you may also be allergic to meropenem. TAKE SPECIAL CARE WITH MEROPENEM Check with your doctor before using Meropenem: • if you have health problems, such as liver or kidney problems. • if you have had severe diarrhoea after taking other antibiotics. You may develop a positive test (Coombs test) which indicates the presence of antibodies that may d Llegiu el document complet
Page 1 of 14 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Meropenem 1 g, powder for solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains meropenem trihydrate equivalent to 1000 mg anhydrous meropenem. The sodium content of each vial is 4.0 mmol (90 mg). After reconstitution with 20 ml diluent the concentration of meropenem amounts to 50 mg/ml. For full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Powder for solution for injection or infusion. White to pale yellow crystalline powder. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Meropenem is indicated for the treatment of the following infections in adults and children over 3 months of age (see sections 4.4 and 5.1): • Pneumonia, including community acquired pneumonia and nosocomial pneumonia. • Broncho-pulmonary infections in cystic fibrosis • Complicated urinary tract infections • Complicated intra-abdominal infections • Intra- and post-partum infections • Complicated skin and soft tissue infections • Acute bacterial meningitis Meropenem may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection. Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The tables below provide general recommendations for dosing. The dose of meropenem administered and the duration of treatment should take into account the type of infection to be treated, including its severity, and the clinical response. A dose of up to 2 g three times daily in adults and adolescents and a dose of up to Page Llegiu el document complet